| Drugname |
Patent Number |
Patent Title |
Patent Assignee |
Estimated Expiration |
| Ecopipam |
➤ Sign Up |
Process for synthesis of D1 receptor antagonists |
Schering Corporation (Kenilworth, NJ) |
➤ Sign Up |
| Ecopipam |
➤ Sign Up |
Active agent delivery systems and methods for protecting and administering active agents |
New River Pharmaceuticals Inc. (Radford, VA) |
➤ Sign Up |
| Ecopipam |
➤ Sign Up |
Selective D1/D5 receptor antagonists for the treatment of obesity and CNS disorders |
Schering Corporation (Kenilworth, NJ) |
➤ Sign Up |
| Ecopipam |
➤ Sign Up |
Active agent delivery systems and methods for protecting and administering active agents |
Shire LLC (Florence, KY) |
➤ Sign Up |
| Ecopipam |
➤ Sign Up |
Selective D.sub.1/D.sub.5 receptor antagonists for the treatment of obesity and CNS disorders |
Schering Corporation (Kenilworth, NJ) |
➤ Sign Up |
| Ecopipam |
➤ Sign Up |
Pharmaceutical propylene glycol solvate compositions |
McNeil-PPC, Inc. (Skillman, NJ) |
➤ Sign Up |
| Ecopipam |
➤ Sign Up |
Pharmaceutical co-crystal compositions |
University of South Florida (Tampa, FL) The Regents of the University of Michigan (Ann Arbor, MI) Transform Pharmaceuticals, Inc. (Lexington, MA) |
➤ Sign Up |
| Drugname |
Patent Number |
Patent Title |
Patent Assignee |
Estimated Expiration |
This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial
